Company Filing History:
Years Active: 2025
Title: Nicole Trainor: Innovator in Oncological Treatments
Introduction
Nicole Trainor is a prominent inventor based in Dundee, GB. She has made significant contributions to the field of oncology through her innovative research and development of novel therapeutic agents.
Latest Patents
Nicole Trainor holds a patent for her invention titled "Proteolysis targeting chimera (PROTACS) as degraders of SMARCA2 and/or SMARCA4." This invention encompasses compounds that serve as degraders of SMARCA2 and/or SMARCA4, which are crucial in the treatment and prevention of oncological diseases. The patent details the specific compounds and their pharmaceutical compositions, highlighting their potential medical uses.
Career Highlights
Nicole has established herself as a key figure in her field, working with Boehringer Ingelheim International GmbH. Her work focuses on developing innovative solutions that address critical health challenges, particularly in cancer treatment.
Collaborations
Nicole collaborates with esteemed colleagues, including Alessio Ciulli and Christian Dank, to advance her research and enhance the impact of her inventions.
Conclusion
Nicole Trainor's contributions to the field of oncology through her innovative patents and collaborations underscore her role as a leading inventor in medical research. Her work continues to pave the way for new therapeutic options in the fight against cancer.